ABBV - AbbVie - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ABBV is currently covered by 22 analysts with an average price target of $199.28. This is a potential upside of $25.58 (14.73%) from yesterday's end of day stock price of $173.7.

AbbVie's activity chart (see below) currently has 389 price targets and 310 ratings on display. The stock rating distribution of ABBV is 80.82% BUY and 19.18% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 89.87% with an average time for these price targets to be met of 490.2 days.

Highest price target for ABBV is $225, Lowest price target is $189, average price target is $199.28.

Most recent stock forecast was given by CHRISTOPHER RAYMOND from PIPER SANDLER on 17-Dec-2024.

Currently out of the existing stock ratings of ABBV, 59 are a BUY (80.82%), 14 are a HOLD (19.18%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$220

$44.83 (25.59%)

$209

1 months ago
(17-Dec-2024)

40/42 (95.24%)

$44.37 (25.26%)

477

Hold

$191

$15.83 (9.04%)

1 months 7 days ago
(10-Dec-2024)

3/4 (75%)

$15.34 (8.73%)

764

Hold

$191

$15.83 (9.04%)

$205

1 months 7 days ago
(10-Dec-2024)

2/4 (50%)

$15.34 (8.73%)

507

Hold

$206

$30.83 (17.60%)

$153

1 months 26 days ago
(22-Nov-2024)

13/14 (92.86%)

$27.92 (15.68%)

293

Buy

$200

$24.83 (14.17%)

$190

2 months 4 days ago
(13-Nov-2024)

12/13 (92.31%)

$28.57 (16.67%)

490

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ABBV (AbbVie) average time for price targets to be met?

On average it took 490.2 days on average for the stock forecasts to be realized with a an average price target met ratio 89.87

Which analyst has the current highest performing score on ABBV (AbbVie) with a proven track record?

JOHN BORIS

Which analyst has the most public recommendations on ABBV (AbbVie)?

John Boris has 1 price targets and 1 ratings on ABBV

Which analyst is the currently most bullish on ABBV (AbbVie)?

Steve Scala with highest potential upside - $49.83

Which analyst is the currently most reserved on ABBV (AbbVie)?

Alex Arfaei with lowest potential downside - -$96.17

AbbVie in the News

Galderma Bets on Skin Drug to Turn Around Pharma Business

Swiss skincare company Galderma is banking on a drug for eczema treatment to revive sales growth at its pharmaceutical business and help it leave behind a hit from patent expirations.

AbbVie Stock Tumbles on Failed Schizophrenia Drug Studies. Bristol Myers Jumps.

Shares of AbbVie were getting hammered Monday after the drug maker said two Phase 2 trials of its experimental schizophrenia drug showed no significant improvement in symptoms. The drug, emraclidine, didn’t meet its “primary endpoint of showing a statistically significant reduction (improvement)” on a widely used scale, compared to the placebo group at week six,...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?